Issue 1, 2010

Analytical protocol for identification of BMAA and DAB in biological samples

Abstract

β-N-methylamino-L-alanine (BMAA) is a non-protein amino acid, thought to be inflicting neurodegenerative diseases related to ALS/PDC in human beings. Due to conflicting data concerning the presence of BMAA in various biological matrixes, we present a robust and sensitive method for high confidence identification of BMAA after derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC). The efficient sample pretreatment in combination with LC-MS/MS SRM enables chromatographic separation of BMAA from the isomer 2,3-diaminobutyric acid (DAB). The method is applicable for selective BMAA/DAB detection in various biological samples ranging from a prokaryotic cyanobacterium to eukaryotic fish.

Graphical abstract: Analytical protocol for identification of BMAA and DAB in biological samples

Article information

Article type
Paper
Submitted
07 Oct 2009
Accepted
16 Nov 2009
First published
26 Nov 2009

Analyst, 2010,135, 127-132

Analytical protocol for identification of BMAA and DAB in biological samples

Z. Spáčil, J. Eriksson, S. Jonasson, U. Rasmussen, L. L. Ilag and B. Bergman, Analyst, 2010, 135, 127 DOI: 10.1039/B921048B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements